FAQ – Heamogene Healthcare

Frequently Asked Questions

What is Next-Generation Sequencing (NGS)?

NGS is an advanced genetic testing technology that enables rapid and comprehensive analysis of DNA and RNA. It plays a crucial role in diagnosing genetic disorders, guiding cancer treatments, and identifying inherited conditions with exceptional accuracy.

Who can benefit from genetic testing?

Genetic testing is valuable for patients with suspected hereditary conditions, cancer patients, individuals with rare diseases, and those seeking personalised treatment plans. Healthcare providers also use genetic insights to make informed decisions.

How does the testing process work?

The process includes:

Sample Collection – A blood or tissue sample is taken from the patient.
Laboratory Analysis – The sample is processed using NGS technology.
Data Interpretation – Experts analyse genetic variations and provide a detailed report.
Clinical Consultation – The results are shared with the patient’s physician for treatment planning.

Where is the testing conducted?

All testing is conducted in collaboration with Health Service Laboratories (HSL) and University College London (UCL), ensuring the highest standards of accuracy and reliability.

How long does it take to receive results?

Turnaround times vary depending on the test type, but most NGS tests provide results within 2 to 4 weeks. Urgent cases can be expedited.

Is genetic testing covered by insurance?

Coverage varies depending on location and insurance providers. We collaborate with healthcare systems and insurers to make testing as affordable as possible. Contact us for further details on coverage options.

Can I access testing if I’m not in the UK?

Yes, we collaborate with international healthcare providers, hospitals, and health ministries to receive and analyse samples from different countries, ensuring global access to genetic testing.

What conditions can NGS testing help diagnose?

NGS is used for various medical applications, including:

Cancer Genomics (Leukaemia, Lymphoma, Solid Tumours)
Hereditary Disorders
Rare Genetic Conditions
Pharmacogenomics (Personalised Drug Response)
Minimal Residual Disease (MRD) Monitoring

Is my genetic information confidential?

Absolutely. We adhere to strict data security protocols and comply with international privacy regulations (GDPR, HIPAA) to ensure your information remains confidential and protected.

How can I get started with genetic testing?

You can speak with your healthcare provider or contact us directly to learn about test options and procedures. We’ll guide you through the process and connect you with the appropriate service.